Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Omega Diagnostics ( (GB:CNSL) ) just unveiled an update.
Cambridge Nutritional Sciences plc announced that Carolyn Rand, the Non-Executive Chair, has purchased 100,000 ordinary shares at 3.59 pence each on February 5, 2025. This acquisition increases her total beneficial holding to 197,500 shares, representing approximately 0.08% of the company’s issued share capital, potentially indicating confidence in the company’s future prospects.
More about Omega Diagnostics
Cambridge Nutritional Sciences plc is a specialist medical diagnostics company focused on promoting a personalized and functional approach to health and nutrition, with industry-leading health and nutrition products.
YTD Price Performance: 25.45%
Average Trading Volume: 480,802
Technical Sentiment Consensus Rating: Hold
Current Market Cap: £8.21M
See more data about CNSL stock on TipRanks’ Stock Analysis page.